Editor´s Pick

      Editor´s Pick

      Teva Announces Appointment of Richard Francis as President and CEO

      TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (“Teva” or the “Company”) (NYSE and TASE: TEVA), today announced that the Company’s Board of Directors has...
      Admin -
      Editor´s Pick

      World-First Inhaled COVID-19 Vaccine, Developed in Partnership Between Aerogen® and CanSinoBIO, First Public Booster Immunization in China.

      GALWAY, Ireland--(BUSINESS WIRE)--Late in 2021, Aerogen® (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) announced a development and commercial supply partnership for...
      Admin -
      Editor´s Pick

      PointClickCare Announces Real World Data Collaboration with Pfizer

      MISSISSAUGA, Ontario--(BUSINESS WIRE)--PointClickCare Technologies, a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights, today announced a strategic collaboration with Pfizer...
      Admin -
      Editor´s Pick

      Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older

      NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced early data from a Phase 2/3 clinical trial...
      Admin -
      Editor´s Pick

      Families of Those Living with a Severe Neurodevelopmental Disorder to Provide Perspective to FDA to Help Expedite New Treatments

      LOS ANGELES--(BUSINESS WIRE)--Families of loved ones living with Phelan-McDermid syndrome (PMS) will inform and educate the U.S. Food and Drug Administration (FDA) and other...
      Admin -
      Editor´s Pick

      Aktana Welcomes New Medical Affairs Lead from IBM Watson Health (Now Merative)

      SAN FRANCISCO--(BUSINESS WIRE)--Aktana, the leader in intelligent customer engagement for the global life sciences industry, welcomes Deepak Patil as its new senior director of...
      Admin -
      123...8Page 2 of 8

      Recent Articles

      Cytonus expands its Scientific Advisory Board with mRNA expert Michael Houston, PhD

      Look Who’s On the Move!

      Switch Therapeutics Expands Leadership Team with Key Appointments

      Industry News

      CANbridge Pharmaceuticals CAN008 Phase 2 Trial for Treatment of Glioblastoma Multiforme (GBM) in China Reaches Full Enrollment

      Industry News

      Avacta Appoints Karen Harrison as Chief Operating Officer for Therapeutics Division

      Look Who’s On the Move!

      Newron Presents Six-Month Interim Data From the First 100 Patients Randomized in Study 014/015 at the 31st European Congress of Psychiatry

      Industry News

      Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib), a Once-Daily Oral Treatment for Adults With Moderate-to-Severe Plaque Psoriasis

      Editor´s Pick

      Silence Therapeutics Appoints Dr. Steven Romano as Incoming Chief Medical Officer and Head of Research and Development

      Look Who’s On the Move!

      Sonoma Biotherapeutics and Regeneron Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases

      Industry News

      Prilenia Achieves Last Patient Last Visit in Phase 3 PROOF-HD Clinical Study for Huntington’s Disease

      Industry News

      Simulations Plus Enters New Strategic Collaboration to Discover Anticancer Therapies Through Its AI-Driven Drug Design Technology

      Industry News

      Virpax Pharmaceuticals Announces Appointment of Barbara A. Ruskin, Ph.D, J.D. to the Board of Directors

      Look Who’s On the Move!

      Andrew Miller Joins Elucid as Chief Technology Officer

      Look Who’s On the Move!

      OncoVerity, Inc. Announces Exclusive Worldwide Licensing Rights to Cusatuzumab and Appoints Max Colao as Chief Executive Officer

      Regulatory Affairs

      ANANDA Scientific Announces First Patient Enrolled in FDA-approved Clinical Trial Evaluating a Potential New Treatment for Social Anxiety Disorder (SAD)

      Regulatory Affairs

      Direct Biologics Announces First Patient Dosed with ExoFlo™ in a Phase 1 Clinical Trial for Medically Refractory Ulcerative Colitis

      Industry News

      2021 © Copyright - TPMG

      Get a free copy of "Cracking the Generics Code"

      Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.